Schermer, Edith E.

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 1,140

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

del Moral-Sánchez, I., Wee, E. G., Xian, Y., Lee, W.-H., Allen, J. D., Torrents de la Peña, A., Rocha, R. F., Ferguson, J., León, A. N., Koekkoek, S., et al. (2023) · npj Vaccines

HIV Research and TreatmentSARS-CoV-2 and COVID-19 Research

Cited by 14

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

del Moral-Sánchez, I., Wee, E. G., Xian, Y., Lee, W.-H., Allen, J. D., Torrents de la Peña, A., Fróes Rocha, R., Ferguson, J., León, A. N., Koekkoek, S., et al. (2024) · npj Vaccines

HIV Research and TreatmentSARS-CoV-2 and COVID-19 Research

Cited by 14